MC10

Cambridge, United States Founded: 2008 • Age: 18 yrs
Miniaturized sensors are embedded in flexible materials for biometric monitoring.

About MC10

MC10 is a Technology company based in Cambridge (United States) founded in 2008 by Ben Schlatka and Carmichael Roberts. Miniaturized sensors are embedded in flexible materials for biometric monitoring. It operates in the Technology and Healthcare sectors. MC10 has raised $117.88 million across 12 funding rounds from investors including Medtronic, Braemar Energy Ventures and North Bridge Venture Partners. Its chief executive, as recorded, is Ben Schlatka. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Remote Patient Monitoring. Its legal entity is MC 10, INC. Its competitors include Sensata, iHealth Labs and Endotronix; 2 of its 3 listed competitors have raised funding.

Company details

MC10 is developing a manufacturing technology that will allow digital circuits to be embedded in fabric or flexible plastic. BioStamp, MC10s first product, is a collection of sensors that can be applied to the skin. The sensors within collect data such as body temperature, heart rate, brain activity, and exposure to ultraviolet radiation. Using near field communication the BioStamp can upload its information to a nearby smartphone for analysis. BioStamp could also be used to verify a persons identity to a computer or mobile device. Another product, Checklight, developed with Reebok, measures velocity and impact to help diagnose concussions in sports.

Key Metrics
  • Total Equity Funding
    $117.88M (USD)

    in 12 rounds

  • Latest Funding Round
    $2.47M (USD), Series C

    Jul 2019

  • Investors
    Medtronic

    & 5 more

Apps and channels of MC10

its YouTube channel Medidata Solutions has 548 subscribers and 14 videos.

Medidata Solutions
YouTube 548 subscribers 14 videos Science & Technology
Open channel

Videos from MC10

The most watched videos on MC10's YouTube channel, Medidata Solutions (548 subscribers). Click a video to play it here.

Beyond the Code: Transforming Clinical Trial Experiences | Medidata
25.8K views
Women’s Health, Digital Therapeutics, and Driving Change in Pharma: Jessica Federer
920 views
Beyond the Code: Transforming Clinical Trial Experiences | Medidata
674 views
Alzheimer’s Treatments, Dementia Early Detection, and the Future of CNS Research: Brad O’Connor
664 views

More on Medidata Solutions.

Funding Insights of MC10

MC10 has successfully raised a total of $117.88M across 12 strategic funding rounds. The most recent funding activity was a Series C round of $2.47 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $117.88M
  • Total Rounds 12
  • Last Round Series C — $2.47M
  • First Round $6.21M

    (Jul 2010)

  • Investors Count 6

Latest 10 of 12 funding rounds of MC10 with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2019$2.47MSeries C––
–
Oct 2018$10.03MSeries C––
–
Aug 2018$2.5MSeries C––
–
Dec 2017$14.98MSeries C––
–
Aug 2017$9.23MSeries C––
–
Dec 2016$5MSeries C––
–
Dec 2013$19.81MSeries C––
–
Apr 2013$8MSeries C––
–
Dec 2012$10MSeries C–Medtronic
Jan 2012$17.15MSeries B–Aberdare Ventures
Valuation history

6 investors in total: 6 institutional.

Investors in MC10

MC10 has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Braemar Energy Ventures and North Bridge Venture Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made in US expansion-stage energy and tech companies.
braemarenergy.comNew York, United States
US focused seed to growth stage VC firm
northbridge.comNeedham, United States
US Life-Sciences sectors are targeted for investment by Aberdare Ventures.
aberdare.comSan Francisco, United States
Early- to growth-stage startups are targeted for venture capital investments.
oup.vcBala Cynwyd, United States
terawattventures.com
Medical equipment for treating over 30 chronic diseases is developed.
1949medtronic.comMinneapolis, United States
Premium access

Investor details for MC10

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of MC10

3 people are tracked at MC10 (2 in leadership, 1 in team).

NameRoleGroup
Ben Schlatka
Co-Founder & CEOLeadership
Carmichael Roberts
Co-FounderLeadership
Harry Gaudette
Senior Manufacturing EngineerTeam
Premium access

Complete people profiles for MC10

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of MC10

3 dated milestones of MC10 across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded MC10 is founded.
  2. Funding First funding round of $6.2M.
  3. Funding Latest funding round, Series C, of $2.5M.

Competitors of MC10

MC10 has 3 listed competitors in our database, 2 of them funded. They include Sensata, iHealth Labs and Endotronix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sensata.com2006Attleboro, United States21,300
Multi-parametric sensors and electronic control systems are manufactured.
ihealthlabs.com2010Mountain View, United States$25M104
Personal healthcare devices for vital monitoring are designed and produced.
endotronix.com2007East Peoria, United States$154.77M104
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
Premium access

Detailed competitors of MC10

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MC10

Websites that share an audience with MC10 (mc10inc.com).

Similar websites

Websites whose visitors overlap most with MC10. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
c-4analytics.com
100%
24.9K#1,477,482View details
leapfrogonline.com
88%
View details
businessweek.com
58%
3.8K#4,720,212View details
en.wikipedia.org
en.wikipedia.org
56%
–
mashable.com
40%
14.9M#5,924View details

Top companies in Embedded & Flexible Electronics

3 companies that operate in the same segment as MC10 (Embedded & Flexible Electronics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
IoT connectivity platform from prototype to production is developed.
2011San Francisco, California, United StatesUSD 134.87 M109
RF MEMS-based oscillators and resonators are supplied for diverse applications.
2004Sunnyvale, California, United StatesUSD 51.97 MUSD 326.66 M395
Flexible displays are researched, developed, and manufactured by Royole.
2012Fremont, California, United StatesUSD 849.93 M78
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mc10

Premium access

Complete news archive for MC10

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MC10

MC10 was founded in 2008 and raised its 1st funding round 2 years after it was founded.

MC10 is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Ben Schlatka is the CEO of MC10, as recorded in our data. They have also founded this company.

MC10 is a funded company, having raised a total of $117.88M across 12 funding rounds to date. The company's 1st funding round was a Series B of $17.15M, raised on Jul 2010.

MC10 is developing a manufacturing technology that will allow digital circuits to be embedded in fabric or flexible plastic. BioStamp, MC10s first product, is a collection of sensors that can be applied to the skin. The sensors within collect data such as body temperature, heart rate, brain activity, and exposure to ultraviolet radiation. Using near field communication the BioStamp can upload its information to a nearby smartphone for analysis. BioStamp could also be used to verify a persons identity to a computer or mobile device. Another product, Checklight, developed with Reebok, measures velocity and impact to help diagnose concussions in sports.

MC10's top competitors include Sensata, Endotronix and iHealth Labs.

MC10 operates through Mc 10, Inc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available